Some years ago, one of us (A.H.E) applied the techniques of pyrolytic gas chromatography and mass spectrometry to the elucidation of mycolic acids structure (4-6, 9, 12-15) . The combination of these and other techniques led to progress in our understanding of these characteristic mycobacterial products (for reviews see references 7 and 8). By 1966 it was possible to obtain precise structural information about submilligram samples of mycolic acids, and we decided to study these constituents of bacteria from leprosy lesions in humans. A brief mention of the results of these investigations was made in a review (6) .
Since that time, an interesting idea has been suggested about the nature of the acid-fast organisms found in the lesions of leprosy. On the basis of observations on the staining properties of these organisms (2, 3) and other undoubted mycobacteria, Fisher and Barksdale (10, 11) have suggested that a diversity of organisms, as opposed to a single mycobacterial species (Mycobacterium leprae), may become acid-fast "leprosy bacilli" in contact with host tissues. It seemed important, therefore, to publish in more detail our findings about the mycolic acids of leprosy bacilli in the hope that they will contribute to a better understanding of the pathogenesis of leprosy.
MATERIALS AND METHODS
Materials collected from skin lesions of patients (30 patients) with lepromatous leprosy were crushed in a mortar and treated with 0.25% trypsin for 5 min at 37 C. After centrifugation and three washings, the precipitate was recovered and suspended in 100 ml of acetone. After a month of contact, the acetone extract was separated by centrifugation, and the sediment was extracted twice with 100 ml of a 50:50 (vol/vol) mixture of ethyl alcohol and diethyl ether. The extract was separated by centrifugation, and the residue was then subjected to three extractions by chloroform. The residue remaining after solvent extractions was saponified by refluxing for 4 h in the presence of 10 ml of 5% methanolic potassium hydroxide; ether-soluble products were extracted, dried over Na2SO4, and treated with diazomethane. Analytical thin-layer chromatography was performed on Silica Gel G plates (10 has shown that mycobacterial residues, after solvent extractions, still contain lipid materials, "firmly bound lipids," from which mycolic acids can be isolated by saponification. We previously observed the richness of these residues in mycolic acids (7), and so we subjected the residue of solvent extractions to saponification. A 500-mg amount of this residue was treated with methanolic potassium hydroxide; the etherosoluble material, separated and treated by diazomethane, was subjected to thin-layer chromatography. By using known compounds as reference samples, we observed that characteristic mycobacterial products, amycolic acids, 0-mycolic acids, pre-a-mycolic acids, and a-meromycolic acids, are present.
Products revealed after being sprayed with rhodamine B were collected by scraping off the materials from the Silica Gel G plate and eluting with diethyl ether. Quantitativelv, 2.8 mg of methyl a-mycolates, 1.2 mg of methyl 13-mycolates, 1 .65 mg of pre-a-mycolates, and 0.3 mg of a-meromycolates were collected in this way. Methyl mycolates were characterized further by mass spectrometry. Mass spectrometric study of characteristic mycobacterial constituents in material from human lesions. We show here only the significant part of the mass spectrum of methyl esters of a-mycolic acids purified from bacteria contained in human lepromatous leprosy lesions (Fig. 1) .
As previously reported ( These compounds undergo further fragmentation characteristic of each of the two categories of substances (for more detailed discussion see references 4 and 6) , and knowledge about these fragments leads to that about the original material. However, since mycolic acids are always mixtures of homologues (7, 8), they show peaks for more than one ester and one aldehyde.
In the particular case of a-mycolic acids of the causative agent of lepromatous leprosy, the structure established by comparison with known compounds is as shown in the following scheme: A series of peaks at m/e = 515, 543, and 571, as well as a series of peaks at M-18, for these fragments exists on the spectrum. The former series of peaks is due to fragmentation following a as shown in scheme V; this allows the calculation of n2 + n3 = 29, 31, and 33. 
